We are live on ! Find out more
FMS icon

Fresenius Medical Care

220 hedge funds and large institutions have $779M invested in Fresenius Medical Care in 2017 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 58 increasing their positions, 62 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 26

7% more funds holding

Funds holding: 205220 (+15)

6% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 62

1.25% less ownership

Funds ownership: 6.06%4.81% (-1.2%)

15% less capital invested

Capital invested by funds: $912M → $779M (-$133M)

Holders
220
Holders Change
+15
Holders Change %
+7.32%
% of All Funds
4.99%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
42
Increased
58
Reduced
62
Closed
26
Calls
$1.13M
Puts
Net Calls
+$1.13M
Net Calls Change
+$813K
Name Holding Trade Value Shares
Change
Change in
Stake
HL
1
Harding Loevner
New Jersey
$210M +$4.28M +86,052 +2%
Morgan Stanley
2
Morgan Stanley
New York
$64.5M +$15.1M +304,238 +33%
Bank of America
3
Bank of America
North Carolina
$44.5M -$51.9M -1,044,625 -55%
Northern Trust
4
Northern Trust
Illinois
$42.1M -$7.4M -149,031 -16%
MAMU
5
Marathon Asset Management (UK)
United Kingdom
$32M -$803K -16,166 -3%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$30.4M +$701K +14,100 +2%
Royal Bank of Canada
7
Royal Bank of Canada
Ontario, Canada
$29.3M -$2.09M -42,058 -7%
PPA
8
Parametric Portfolio Associates
Washington
$25.3M +$2.46M +49,513 +11%
US Bancorp
9
US Bancorp
Minnesota
$16.2M -$4.52M -91,010 -23%
JFL
10
Jarislowsky, Fraser Ltd
Quebec, Canada
$15.7M +$201K +4,038 +1%
Allianz Asset Management
11
Allianz Asset Management
Germany
$15.1M +$880K +17,713 +7%
TIM
12
Thornburg Investment Management
New Mexico
$12.5M +$2.03M +40,914 +21%
Envestnet Asset Management
13
Envestnet Asset Management
Illinois
$12.2M -$1.46M -29,335 -11%
Goldman Sachs
14
Goldman Sachs
New York
$12.2M +$135K +2,719 +1%
AG
15
Aperio Group
California
$11.5M +$408K +8,210 +4%
GCC
16
Guardian Capital (Canada)
Ontario, Canada
$11.3M +$1.99M +40,026 +23%
State Farm Mutual Automobile Insurance
17
State Farm Mutual Automobile Insurance
Illinois
$9.49M
Invesco
18
Invesco
Georgia
$8.85M -$484K -9,752 -5%
FWCM
19
Ferguson Wellman Capital Management
Oregon
$7.42M +$50.7K +1,020 +0.7%
Boston Partners
20
Boston Partners
Massachusetts
$5.61M -$1.04M -20,997 -16%
William Blair Investment Management
21
William Blair Investment Management
Illinois
$5.54M +$940K +18,924 +22%
First Trust Advisors
22
First Trust Advisors
Illinois
$5.47M -$83.6K -1,683 -2%
Renaissance Technologies
23
Renaissance Technologies
New York
$4.98M +$1.48M +29,768 +46%
MWNA
24
Marshall Wace North America
New York
$4.85M +$3.79M +76,318 +479%
Truist Financial
25
Truist Financial
North Carolina
$4.38M -$850K -17,102 -17%

FMS Hedge Fund Activity: Q4 2017 in Review

220 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Fresenius Medical Care (FMS) for Q4 2017, worth a combined $779M — down 15% from $912M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new FMS positions and 26 closed out — a net gain of 16 holders — while 58 added to existing stakes and 62 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $15.1M. The largest seller was Cambiar Investors, cutting an estimated $132M.

  • 220 institutional investors held Fresenius Medical Care (FMS) as of Q4 2017, up from 205 in Q3 2017.
  • Funds reported $779M of Fresenius Medical Care stock for Q4 2017, down 15% quarter-over-quarter.
  • 42 funds opened new Fresenius Medical Care positions in Q4 2017 and 26 closed out, a net change of +16 holders.
  • The largest Fresenius Medical Care buyer in Q4 2017 was Morgan Stanley, an estimated $15.1M added.
  • The largest Fresenius Medical Care seller in Q4 2017 was Cambiar Investors, an estimated $132M sold.

Based on aggregated 13F filings for Q4 2017.